Skip to content

Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study

Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07111364
Acronym
BCA-AI-US
Enrollment
400
Registered
2025-08-08
Start date
2025-05-27
Completion date
2026-05-31
Last updated
2025-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer, Deep Learning, Ultrasound

Brief summary

This study aims to develop an ultrasound image-based deep learning system to enable automatic segmentation, T-staging, and pathological grading prediction of bladder tumors. It seeks to enhance the objectivity, accuracy, and efficiency of bladder cancer diagnosis, reduce reliance on physician experience, and provide support for precision medicine and resource optimization.

Interventions

observational diagnostic model development

Sponsors

Peking University First Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

① Suspected bladder mass detected by abdominal ultrasound (age ≥18 years);② Patients scheduled for surgical treatment of bladder tumors.

Exclusion criteria

* Age \>85 years; * Patients unable to undergo abdominal/transrectal ultrasound (e.g., uncooperative individuals, technically inadequate images); * History of bladder tumor surgery, radiotherapy, chemotherapy, or systemic therapy within 3 months; ④ Patients with indwelling medical devices (e.g., double-J ureteral stents, urinary catheters); * Failure to undergo bladder tumor surgery within 2 weeks post-ultrasound; ⑥ Non-urothelial carcinoma or pathologically unconfirmed diagnoses.

Design outcomes

Primary

MeasureTime frame
Overall Diagnostic AccuracyFrom may 2025 to may 2027

Countries

China

Contacts

Primary ContactZheng Zhang
doczhz@aliyun.com+86 139 0137 1490

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026